Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery
Dauer: 48 Monate, Fördersumme: € 899.630
Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas
Dauer: 48 Monate, Fördersumme: € 899.160
Navigating landscapes of admixture
Dauer: 96 Monate, Fördersumme: € 1.599.900
Decoding cellular senescence in glioblastoma (GlioAge)
Dauer: 36 Monate, Fördersumme: € 898.970
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Dauer: 48 Monate, Fördersumme: € 799.510
Deciphering genomic aberrations in rare skin cancers to find mechanism-based treatment strategies
Dauer: 82 Monate, Fördersumme: € 972.100